Efficient induction of antitumor immunity by synthetic toll-like receptor ligand-peptide conjugates

Cancer immunology research

Volumn 2, Issue 8, 2014, Pages 756-764

  Zom, Gijs G ^a   Khan, Selina ^a   Britten, Cedrik M ^a   Sommandas, Vinod ^a   Camps, Marcel G M ^a   Loof, Nikki M ^a   Budden, Christina F ^a   Meeuwenoord, Nico J ^a   Filippov, Dmitri V ^a   van der Marel, Gijsbert A ^a   Overkleeft, Hermen S ^a   Melief, Cornelis J M ^a   Ossendorp, Ferry ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; LIGAND; LIPOPEPTIDE; PAM(3)CSK(4) PEPTIDE; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

AGONISTS; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINE; DENDRITIC CELL; IMMUNOLOGY; LYMPHOMA; MELANOMA, EXPERIMENTAL; PATHOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL LINE, TUMOR; DENDRITIC CELLS; LIGANDS; LIPOPEPTIDES; LYMPHOMA; MELANOMA, EXPERIMENTAL; MICE, INBRED C57BL; MICE, TRANSGENIC; TOLL-LIKE RECEPTOR 2; TUMOR BURDEN;

EID: 84912075633     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-13-0223     Document Type: Article

References (0)